版本:
中国

BRIEF-James Flynn reports 4.21 pct passive stake in Catabasis Pharma - SEC filing

Sept 30 (Reuters) -

* James Flynn reports 4.21 percent passive stake in Catabasis Pharmaceuticals Inc as of September 28 - SEC filing Source text bit.ly/2dJKqb2 Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐